NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Let me quote the part of the court case that I have quoted to you many times ExW:

A review of the record in its entirety leaves as the only reasonable inference that the data monitoring committee had reviewed only safety data from the Phase III trials, not efficacy data.

Plaintiffs could have filed again or amended to address this if it were an error. The updated SAP which I just previously quoted appears to validate that decision.